CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.

A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group ...

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

A study led by a researcher based at King's College London and McMaster University in Canada reveals how CAR-T cell therapy, a treatment that engineers a patient's own immune cells to recognize and ...

Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...

Leading CAR T cell therapy researchers have developed a human-in-the-loop artificial intelligence (AI) framework that centers ...

CAR-T therapy is a highly specialized treatment that requires careful patient selection and close monitoring. Some patients ...

I f your doctor has recommended chimeric antigen receptor (CAR) T-cell immunotherapy for large B-cell lymphoma (LBCL), you’ve likely already tried several standard treatments, and the cancer did not ...

CAR T-cell therapy was first developed as a lymphoma treatment but has recently been applied to autoimmune diseases such as lupus. This study examined a novel method that transforms patients' T cells ...

U.S. pharmaceutical company Moderna announced on the 26th (local time) that it will begin developing an “in vivo CAR-T” ...

At its latest R&D update, Moderna revealed a move into the pioneering in vivo CAR-T category, adding another treatment class ...